[Editor's Note:This article was updated on 26 July with new information about the pricing for Lingo in the UK.]
Abbott's long-awaited biowearable made its
Abbott’s Lingo Biowearable For Consumers Debuts In The UK As Libre Momentum Continues
Abbott launched its first biowearable for consumers in the UK with plans to expand in Europe and the US. Analysts are optimistic about continued growth of Libre FreeStyle amid drivers such as CGM adoption by non-insulin users, expected 15-day sensor, streaming capability and integration with Tandem insulin pump.
